JeNaCell Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

JeNaCell General Information

Description

Developer of bio-technologically derived cellulose designed to manufacture medicines. The company's nano cellulose has a defined shape and controllable structural design that helps clients create innovative and future-oriented products in the fields of medicine, cosmetics, technology and pharmacy, enabling users to protect their skin from chronic wounds with the use of laser treatments and aesthetic dermatology.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • Göschwitzer Stasse 22
  • 07745 Jena
  • Germany
+49
Primary Industry
Medical Supplies
Parent Company
Vertical(s)
Corporate Office
  • Göschwitzer Stasse 22
  • 07745 Jena
  • Germany
+49

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JeNaCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 02-Aug-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 07-Jul-2015 Completed Generating Revenue
3. Seed Round 11-Oct-2012 Completed Startup
2. Grant 20-Jun-2012 $18.8K Completed Startup
1. Grant 15-Mar-2012 Completed Startup
To view JeNaCell’s complete valuation and funding history, request access »

JeNaCell Patents

JeNaCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025210343-A1 Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose Pending 15-Jan-2024
WO-2025153330-A1 Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose Inactive 15-Jan-2024
EP-3406728-A1 Method for producing bacterially synthesized cellulose non-woven Active 24-May-2017
EP-3406728-B1 Method for producing bacterially synthesized cellulose non-woven Active 24-May-2017
EP-3630992-A1 Method for producing bacterially synthesized cellulose non-woven Pending 24-May-2017 C12P19/04
To view JeNaCell’s complete patent history, request access »

JeNaCell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

JeNaCell Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Evonik Venture Capital Corporate Venture Capital Minority
Foundation for Technology, Innovation and Research Thuringia Corporation Minority
Germany's Federal Ministry of Economics and Technology Government
Science4Life Accelerator/Incubator
Sparkasse Jena Investment Bank Minority
You’re viewing 5 of 6 investors. Get the full list »

JeNaCell FAQs

  • When was JeNaCell founded?

    JeNaCell was founded in 2012.

  • Where is JeNaCell headquartered?

    JeNaCell is headquartered in Jena, Germany.

  • What is the size of JeNaCell?

    JeNaCell has 12 total employees.

  • What industry is JeNaCell in?

    JeNaCell’s primary industry is Medical Supplies.

  • Is JeNaCell a private or public company?

    JeNaCell is a Private company.

  • What is JeNaCell’s current revenue?

    The current revenue for JeNaCell is .

  • How much funding has JeNaCell raised over time?

    JeNaCell has raised $907K.

  • Who are JeNaCell’s investors?

    Evonik Venture Capital, Foundation for Technology, Innovation and Research Thuringia, Germany's Federal Ministry of Economics and Technology, Science4Life, and Sparkasse Jena are 5 of 6 investors who have invested in JeNaCell.

  • When was JeNaCell acquired?

    JeNaCell was acquired on 02-Aug-2021.

  • Who acquired JeNaCell?

    JeNaCell was acquired by Evonik Industries and High-Tech Gründerfonds.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process